A
Ahmad Al-Sayyad
Researcher at King Abdulaziz University
Publications - 8
Citations - 342
Ahmad Al-Sayyad is an academic researcher from King Abdulaziz University. The author has contributed to research in topics: Varicocele & Gene expression profiling. The author has an hindex of 6, co-authored 8 publications receiving 291 citations.
Papers
More filters
Journal ArticleDOI
Does varicocele repair improve male infertility? An evidence-based perspective from a randomized, controlled trial.
Taha A. Abdel-Meguid,Taha A. Abdel-Meguid,Ahmad Al-Sayyad,Abdulmalik M. Tayib,Hasan M.A. Farsi +4 more
TL;DR: The authors' RCT provided level 1b evidence of the superiority of varicocelectomy over observation in infertile men with palpable varicoCEles and impaired semen quality, with increased odds of spontaneous pregnancy and improvements in semen characteristics within 1-yr of follow-up.
Journal ArticleDOI
Re: Effects of Varicocele on Serum Testosterone and Changes of Testosterone after Varicocelectomy: A Prospective Controlled Study
Taha A. Abdel-Meguid,Taha A. Abdel-Meguid,Hasan M.A. Farsi,Ahmad Al-Sayyad,Abdulmalik M. Tayib,Hisham A. Mosli,Abdulghafour H. Halawani +6 more
TL;DR: Baseline T was significantly low in men with varicocele compared with normal men and improvements were persistent at 12-month follow-up, and T changes correlated strongly and significantly with baseline T and sperm concentrations.
Journal Article
Tamsulosin to treat uncomplicated distal ureteral calculi: a double blind randomized placebo-controlled trial.
TL;DR: Tamsulosin therapy for uncomplicated distal ureteral calculi augments SPR, shortens passage time and decrease need for analgesia, and augments the passage rate for larger stones.
Journal ArticleDOI
Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
Sajjad Karim,Jaudah Al-Maghrabi,Hasan M.A. Farsi,Ahmad Al-Sayyad,Hans-Juergen Schulten,Abdelbaset Buhmeida,Zeenat Mirza,Alaa A. Al-boogmi,Fai T. Ashgan,Manal M. Shabaad,Hend Fakhri NourEldin,Khalid B. Al-Ghamdi,Adel M. Abuzenadah,Adeel G. Chaudhary,Mohammed H. Al-Qahtani +14 more
TL;DR: Docking study showed that CCND1 may act as a potential therapeutic target and its inhibition could focus on the migratory, invasive, and metastatic potential of RCC.
Journal Article
Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
Taha A. Abdel-Meguid,Hisham A. Mosli,Hasan M.A. Farsi,Ahmad Al-Sayyad,Abdulmalik M. Tayib,Moataz Sait,Ahmad Abdelsalam +6 more
TL;DR: OnaBoNT-A intraprostatic injections appeared to be effective and safe to ameliorate symptoms of refractory nonbacterial CP/CPPS; with pain most improved; with improvements gradually dwindled at 9-12 months.